Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4663

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Oxcarbazepine 300 mg film-coated tablets label showing a bottle containing 30 tablets. The label includes the NDC number 70518-4663-00, repackager RemedyRepack Inc. in Indiana, PA, and manufacturer Breckenridge in Boca Raton, FL. Storage instructions and a QR code are also visible.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing its molecular framework with a central seven-membered ring containing a ketone and amide functional groups, flanked by two benzene rings.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier plot showing the exit rate over time on trial from Day 2 to Day 11 at 8 am, comparing treatment groups of Oxcarbazepine tablets, film coated 300 mg and placebo. The graph includes a log-rank test p-value of 0.0001, indicating a significant difference between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A survival curve chart comparing seizure rates over time between Oxcarbazepine and placebo treatment groups. The x-axis shows days from first dose to first seizure, ranging from 0 to 140 days, and the y-axis represents the seizure rate from 0.0 to 1.0. The Oxcarbazepine group shows a lower seizure rate over time compared to placebo. The chart includes a log-rank test p-value of 0.046 indicating statistical comparison between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier curve chart depicting exit rate over time (days) for two treatment groups labeled as HIGH and LOW. The x-axis shows time to exit in days up to 130 days, while the y-axis shows the exit rate from 0.0 to 1.0. The chart includes a log-rank test p-value of 0.0001, indicating a statistically significant difference between the groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier plot showing exit rate over time (days) for two treatment groups labeled 'HIGH' and 'LOW', distinguished by solid and dashed lines. The plot includes a log-rank test p-value of 0.0001, indicating a statistical comparison between the groups' exit rates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.